Multicenter phase 2 study of induction chemotherapy with docetaxel and nedaplatin for oral squamous cell carcinoma

被引：0
|
作者：
Hiroshi Kurita
Etsuhide Yamamoto
Shinichi Nozaki
Shigehito Wada
Isao Furuta
Masaru Miyata
Kenji Kurashina
机构：
[1] Shinshu University School of Medicine,Department of Dentistry and Oral Surgery
[2] Kanazawa University Graduate School of Medical Science,Department of Oral and Maxillofacial Surgery
[3] National Hospital Organization Kanazawa Medical Center,Department of Oral and Maxillofacial Surgery
[4] University of Toyama,Department of Oral and Maxillofacial Surgery, Faculty of Medicine
[5] Ishikawa Prefectural Center Hospital,Department of Oral and Maxillofacial Surgery
来源：
Cancer Chemotherapy and Pharmacology | 2010年 / 65卷
关键词：
Neoadjuvant chemotherapy; Squamous cell carcinoma; Docetaxel; Nedaplatin; Oral cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：503 / 508
页数：5
相关论文
共 50 条
  • [31] A Phase II Study of Adjuvant Chemotherapy with Docetaxel plus Nedaplatin for Completely Resected Non-Small Cell Lung Cancer
    Teramoto, K.
    Namura, Y.
    Hayashi, K.
    Ishida, K.
    Ueda, K.
    Okamoto, K.
    Kaku, R.
    Hori, T.
    Kawaguchi, Y.
    Igarashi, T.
    Hashimoto, M.
    Ohshio, Y.
    Kitamura, S.
    Motoishi, M.
    Suzumura, Y.
    Sawai, S.
    Hanaoka, J.
    Daigo, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1963 - S1964
  • [32] A phase II study of docetaxel plus nedaplatin in patients with metastatic non-small-cell lung cancer
    Koji Teramoto
    Yoshikuni Asada
    Yoshitomo Ozaki
    Yuji Suzumura
    Yasutaka Nakano
    Satoru Sawai
    Noriaki Tezuka
    Shuhei Inoue
    Shozo Fujino
    Cancer Chemotherapy and Pharmacology, 2012, 70 : 531 - 537
  • [33] Phase II trial of second-line chemotherapy with docetaxel and capecitabine in advanced esophageal squamous cell carcinoma
    Li, Xuyuan
    Lin, Wen
    Wang, Hongbiao
    Lin, Wenzhao
    Lin, Suiling
    Lin, Yingcheng
    MEDICAL ONCOLOGY, 2013, 30 (04)
  • [34] A phase II study of docetaxel plus nedaplatin in patients with metastatic non-small-cell lung cancer
    Teramoto, Koji
    Asada, Yoshikuni
    Ozaki, Yoshitomo
    Suzumura, Yuji
    Nakano, Yasutaka
    Sawai, Satoru
    Tezuka, Noriaki
    Inoue, Shuhei
    Fujino, Shozo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 70 (04) : 531 - 537
  • [35] Phase II study of neoadjuvant chemotherapy with irinotecan hydrochloride and nedaplatin followed by radical hysterectomy for bulky stage Ib2 to IIb, cervical squamous cell carcinoma: Japanese Gynecologic Oncology Group study (JGOG 1065)
    Yamaguchi, Satoshi
    Nishimura, Ryuichiro
    Yaegashi, Nobuo
    Kiguchi, Kazushige
    Sugiyama, Toru
    Kita, Tsunekazu
    Kubushiro, Kaneyuki
    Kokawa, Katsuji
    Hiura, Masamichi
    Mizutani, Katsumi
    Yamamoto, Kaichiro
    Takizawa, Ken
    ONCOLOGY REPORTS, 2012, 28 (02) : 487 - 493
  • [36] Phase I study of cisplatin analogue nedaplatin (254-S) and paclitaxel in patients with unresectable squamous cell carcinoma
    I Sekine
    H Nokihara
    A Horiike
    N Yamamoto
    H Kunitoh
    Y Ohe
    T Tamura
    T Kodama
    N Saijo
    British Journal of Cancer, 2004, 90 : 1125 - 1128
  • [37] Docetaxel Plus Nedaplatin or Carboplatin as Second-Line Chemotherapy for Advanced Lung Squamous Cell Carcinoma in Real-World Practice: A Single-Center Experience
    Zhong, Jian
    Zhang, Qian
    Li, Li
    Xu, Chunhua
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2023, 22
  • [38] Phase I study of cisplatin analogue nedaplatin (254-S) and paclitaxel in patients with unresectable squamous cell carcinoma
    Sekine, I
    Nokihara, H
    Horiike, A
    Yamamoto, N
    Kunitoh, H
    Ohe, Y
    Tamura, T
    Kodama, T
    Saijo, N
    BRITISH JOURNAL OF CANCER, 2004, 90 (06) : 1125 - 1128
  • [39] Induction chemotherapy with cisplatin/docetaxel versus cisplatin/5-fluorouracil for locally advanced squamous cell carcinoma of the head and neck:: A randomised phase II study
    Fonseca, E
    Grau, JJ
    Sastre, J
    García-Gómez, JM
    Rueda, A
    Pastor, M
    Lara, MA
    Navalón, M
    Berrocal, A
    Tisaire, JL
    Cruz, JJ
    EUROPEAN JOURNAL OF CANCER, 2005, 41 (09) : 1254 - 1260
  • [40] Phase I dose-escalation study of docetaxel, nedaplatin, and 5-fluorouracil combination chemotherapy in patients with advanced esophageal cancer
    Miyazaki, Tatsuya
    Sohda, Makoto
    Tanaka, Naritaka
    Suzuki, Shigemasa
    Ieta, Keisuke
    Sakai, Makoto
    Sano, Akihiko
    Yokobori, Takehiko
    Inose, Takanori
    Nakajima, Masanobu
    Fukuchi, Minoru
    Ojima, Hitoshi
    Kato, Hiroyuki
    Kuwano, Hiroyuki
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (04) : 853 - 857
12345